What is TRexit?

Australia has been leading the world in its practice of performing prostate biopsy via the skin (Transperineal Biopsy) instead of via the rectum (Transrectal). Movember’s Prostate Cancer Outcomes Registry shows that in Victoria, the majority of prostate biopsies are now performed via the skin. In 2013, it was only 5%.

There are 2 major advantages to patients. Our research has shown that the sepsis rate when performing prostate biopsy via the skin is zero or near zero. This is in contrast to the increasing rates of sepsis from transrectal biopsy we are seeing worldwide.

Secondly, no antibiotics are needed for Transperineal biopsy. This makes the wider community safer, as it avoids the promotion of multi-resistant bacteria (superbugs).

The world is taking notice, with the switch from Transrectal to Transperineal prostate biopsy - TRexit - gaining momentum. Here’s an article I wrote with leaders in this field from around the world to raise awareness and advocate for patient safety: https://go.nature.com/3cmimWm